Barclays reiterates Overweight on ASML stock, EUR1,500 target By Investing.com

ASML raised full-year revenue guidance to EUR36-40 billion from EUR34-39 billion, with orders still described as very strong and non-EUV business now expected to grow instead of remain flat. Barclays reiterated an Overweight rating and EUR1,500 price target, while the company said it can deliver at least 60 EUV low NA units in 2026 and at least 80 in 2027 if demand supports it. First-quarter 2026 results showed EUR8.8 billion in net sales and a 53% gross margin, reinforcing the positive operational outlook.

Analysis

The setup is still fundamentally constructive, but the real story is not the headline guidance raise — it’s the optionality embedded in throughput and mix. Higher EUV productivity means ASML can monetize installed-demand faster without needing proportional unit growth, which should support margin stability even if macro capex pauses. More importantly, a stronger non-EUV outlook suggests the customer base is broadening beyond the “leading-edge only” cohort, reducing dependence on a handful of frontier-node buyers and extending the cycle.

The second-order winner is the semiconductor supply chain that benefits from earlier capacity unlocks: equipment adjacencies, specialty materials, and advanced packaging names should see a lagged but real demand pull-through as foundries and memory producers accelerate node transitions. The main loser is anyone short the capex cycle on the assumption that export controls or a digestion phase will cap orders quickly; this guidance implies customers are still racing to secure tool slots, which usually persists for multiple quarters once it starts.

The contrarian issue is valuation versus durability. When a stock is near highs with expectations already elevated, the next leg is rarely driven by revenue alone — it needs either sustained margin upside or a clearer acceleration in EUV adoption cadence. The market may be underestimating how much of the upside is already in the price, but it may also be underestimating how sticky the order book becomes if customers are still capacity constrained into 2026-27.

Tail risks sit on three clocks: near-term export control headlines can re-rate the multiple in days; customer digestion could slow bookings over 1-2 quarters; and a broader semiconductor end-market slowdown could matter over 6-12 months. The highest-risk assumption is that guidance can keep stepping up without a corresponding demand air pocket — if that happens, the stock can de-rate quickly despite strong fundamentals.

Key Decisions for Investors

• Stay long ASML, but prefer call spreads over outright stock for the next 3-6 months to express upside while capping valuation risk; the best setup is on any 3-5% post-earnings pullback.
• Pair long ASML vs short a higher-beta semiconductor equipment name with weaker backlog visibility over the next quarter; the goal is to isolate quality-of-demand and pricing power rather than beta.
• Add exposure to EUV-adjacent supply chain beneficiaries on weakness for a 6-12 month horizon; the mechanism is delayed pull-through from higher tool output and broader capacity expansion.
• Use export-control headlines as a tactical hedge trigger: if policy rhetoric tightens, trim 20-30% of the position or overlay downside puts, since multiple compression would likely hit before fundamentals do.
• For new money, wait for confirmation in the next order cycle rather than chasing highs; risk/reward improves materially if the market offers a better entry after any digestion-related volatility.